AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 81 min read$YDES

Shen Ethan PhD purchased $67K of YDES

Shen Ethan PhD (CEO) purchased 18,378 shares of YD Bio Ltd (YDES) at $3.67 on 2026-09-04.

Original reporting
SEC EDGAR · Shen Ethan PhD
Published Sep 8, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$YDES
Neutral
high confidence
Mentioned
$YDES
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$YDESNeutralLow
01

Why it matters

The $67k purchase is modest and unlikely to affect YDES stock price in the short term.

02

Market read

Primary disclosure of a small insider buy; limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed could make this purchase more meaningful.

Relevance 4/10Novelty 3/10Timing: filed after market on 2026-09-08

Background

Form 4 filing reports insider transactions; investors monitor CEO purchases for confidence signals.

Company-level read

Ticker impact

$YDESNeutralHigh confidence
Context

CEO Shen Ethan purchased 18,378 shares at $3.67 each, total $67,447, increasing his stake to 11,242,531 shares.

Expected impact

minimal or no immediate price change

Evidence & confidence

Purchase size is modest relative to float; market typically discounts such small transactions.

Market effects

Sector

None; insider activity does not affect sector trends.

Regional

None; company is micro‑cap with limited regional influence.

Global

None; event is company‑specific.

Counterpoint

What could challenge this read

Even small insider purchases can signal confidence; watch for future buying trends.

Key entities

  • Individual
    Shen Ethan PhD

    CEO of YD Bio Ltd.

  • Company
    YD Bio Ltd

    Biotech firm listed under ticker YDES.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

YDES insider trading history →

Related articles

AUG 31
$YDESMed

YD Bio Ltd (YDES): Financial results for H1 2026

YD Bio Ltd (YDES) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026 TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detec

SEC EDGAR 6-K2 min
JUL 7
$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.

rttnews.com6 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min